New hope for hepatitis b patients after treatment fails?
NCT ID NCT04496882
Summary
This study is for people with chronic hepatitis B who stopped their antiviral medication, then had a dangerous flare-up of the virus. It tests if switching to a newer drug called tenofovir alafenamide (TAF) is effective at getting the virus back under control and protecting the liver. Researchers will compare results to a group of similar patients who restart their old medication instead.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Buddhist Tzu Chi General Hospital, Da-Lin Branch
Chiayi City, Taiwan
-
Buddhist Tzu-Chi General Hospital Taipei Branch
Taipei, Taiwan
-
Chia-Yi Christian Hospital
Chiayi City, Taiwan
-
E-da hospital
Kaohsiung City, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
National Taiwan University Hospital ,Hsin-Chu Branch
Hsinchu, Taiwan
-
National Taiwan University Hospital, Yun-Lin branch
Douliu, Taiwan
-
Taipei City Hospital, Renai Branch
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.